Cytotoxic T cell response against the chimeric ETV6-AML1 protein in childhood acute lymphoblastic leukemia. - Wikidata - wikimedia - TriplyDB

Cytotoxic T cell response against the chimeric ETV6-AML1 protein in childhood acute lymphoblastic leukemia.

Cytotoxic T cell response against the chimeric ETV6-AML1 protein in childhood acute lymphoblastic leukemia.

http://www.wikidata.org/entity/Q37384003

about

BMP-6 inhibits growth of mature human B cells; induction of Smad phosphorylation and upregulation of Id1 AML1 interconnected pathways of leukemogenesis Immunotherapy in acute leukemia T-cell-based therapies for malignancy and infection in childhood.MLL-rearranged B lymphoblastic leukemias selectively express the immunoregulatory carbohydrate-binding protein galectin-1.Identification of a human telomerase reverse transcriptase peptide of low affinity for HLA A2.1 that induces cytotoxic T lymphocytes and mediates lysis of tumor cells.Gene therapy for paediatric leukaemia.T-cell therapy of leukemia.Adoptive cellular therapy: a therapeutic reality?The prioritization of cancer antigens: a national cancer institute pilot project for the acceleration of translational research.Tumor-associated antigens: from discovery to immunity.Absence of leukaemic fusion gene transcripts in preterm infants exposed to diagnostic x rays Immunotherapy targets in pediatric cancer.Interferon alpha and T-cell responses in chronic myeloid leukemia.Identification of a novel major histocompatibility complex class II-restricted tumor antigen resulting from a chromosomal rearrangement recognized by CD4(+) T cells.Augmentation of anti-tumor immunity by adoptive T-cell transfer after allogeneic hematopoietic stem cell transplantation.Telomerase immunity from bench to bedside: round one.A pilot study of consolidative immunotherapy in patients with high-risk pediatric sarcomas.Mobilizing the low-avidity T cell repertoire to kill tumors.Novel molecular and cellular therapeutic targets in acute lymphoblastic leukemia and lymphoproliferative disease.Insights into the processing of MHC class I ligands gained from the study of human tumor epitopes.Pilot trial of tumor-specific peptide vaccination and continuous infusion interleukin-2 in patients with recurrent Ewing sarcoma and alveolar rhabdomyosarcoma: an inter-institute NIH study.Identification of a novel WT1-derived peptide which induces human leucocyte antigen-A24-restricted anti-leukaemia cytotoxic T lymphocytes.Human Tumor Antigens and Cancer Immunotherapy.Histone deacetylase inhibition improves differentiation of dendritic cells from leukemic blasts of patients with TEL/AML1-positive acute lymphoblastic leukemia.Identification and Characterization of Neoantigens As Well As Respective Immune Responses in Cancer Patients.Transplantation for Childhood Acute Lymphoblastic Leukemia

P2860

Q24806130-9FC9B38F-BF6F-465F-A567-D53D822E84C0 Q28184349-87F15EAB-C4AE-4950-9507-99CFA030E1EA Q33731552-F6CFF073-CE93-40ED-A915-2700B5C2A576 Q33750862-4C041434-8F4B-4ED1-A294-28C2ED6D907B Q34060270-53E8107C-238A-444F-8088-338E76E24C96 Q34155839-09095098-B85C-4B9D-A1B6-E065976F826B Q34451905-22104E62-BA38-4266-9018-0024D2B0D82D Q34608658-371856DE-9F0D-4E8A-8B75-E5FB65FF73A0 Q34875170-4C16F481-3FA4-4D8F-8E5C-601B74B25BE6 Q35000726-1313586D-9555-452D-B244-90D5F8510F2A Q35214398-6C0A0B6F-9A65-420C-BBE3-13B2B4423308 Q35293385-E7C9A42E-CC3F-4A13-94F5-DD40B901884B Q35971029-20FB734E-4C85-4FE0-9F45-E22F89C396FB Q35994924-E6DED46D-A00E-499E-86BE-4793DBF18FDC Q36369960-E2BA7C89-8B0A-4467-AF2C-EF34A406F486 Q36662079-A9AFB86F-7258-4979-BCA3-6775E4FAF591 Q36745749-0F2C067C-92FA-4553-B7BC-1B7D4BAFE8AB Q36813562-7E963794-6C95-4775-8CF6-7D4960CCFBC4 Q36891310-E4FBA5EC-BAAB-41AF-8EE2-365BDA52C8DC Q37248354-930DCCE3-00A2-4204-9CB4-408F9AD1E2DE Q37851050-15C2FF0E-5D26-477B-B8E6-5A00E1D24C2F Q40661469-C93B8FF6-7EC2-4C4E-B2BF-05527DF01481 Q40750584-B481EF9A-BF46-4569-8BA8-AF2A63B492B0 Q41533232-E484FDD1-263F-4F4B-9827-DB17DB24EB48 Q46171835-FA229C2D-D3A5-46ED-A27B-2BECCED3124B Q47133741-7FB6D408-D7E1-447B-A153-1DEFD632A7B2 Q59094157-CAB6C68F-99DD-4778-A49B-7DE9D6D24EC9

P2860

Cytotoxic T cell response against the chimeric ETV6-AML1 protein in childhood acute lymphoblastic leukemia.

http://www.wikidata.org/entity/Q37384003

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on July 1998

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Cytotoxic T cell response agai ...... acute lymphoblastic leukemia.

@en

Cytotoxic T cell response agai ...... acute lymphoblastic leukemia.

@nl

type

label

Cytotoxic T cell response agai ...... acute lymphoblastic leukemia.

@en

Cytotoxic T cell response agai ...... acute lymphoblastic leukemia.

@nl

prefLabel

Cytotoxic T cell response agai ...... acute lymphoblastic leukemia.

@en

Cytotoxic T cell response agai ...... acute lymphoblastic leukemia.

@nl

P1433

Q37384003-7473103E-BB9A-4682-BE18-CD4A7AC6A543

P1476

Q37384003-05BB2170-D913-4AEE-82D9-223A92E11956

P2093

Q37384003-06420345-0510-44F4-873F-71407BB9D04A

Q37384003-144C3908-A54D-4947-A1B9-8DE54EAC53D8

Q37384003-4396AE5B-F7D8-4580-B84D-62615FB85311

Q37384003-54BE41CB-4341-4FEE-B129-ED6C629D4C22

Q37384003-665C3630-CDBC-42A1-99B6-4233A3F4D459

Q37384003-A3F3C532-05B9-4A45-8076-F7E6B8200B82

Q37384003-C8FDF703-0D81-4914-AA93-0FCDC58004EA

Q37384003-EA674F19-751D-4842-B53C-E6DC572F14F7

P2860

Q37384003-111232FB-7C20-4C58-AF6A-762E00B15F70

Q37384003-23A396B4-38F9-48E2-99A5-26391EABBF04

Q37384003-2B814382-9E09-4754-A915-0A7D4B11D292

Q37384003-31BCF630-0D4E-42C3-9D4D-219406B75F7E

Q37384003-3E5FEA58-244A-4CE8-8EE4-E51A1532D060

Q37384003-571779FF-2617-438D-8303-898BC05B233C

Q37384003-671D4E3E-D36F-4081-ADA1-1F86B97A5853

Q37384003-81311DCF-4F28-49AD-8976-28DFAAD95EBE

Q37384003-92F0A893-953E-4041-AA97-C8D5A4438063

Q37384003-95504D94-9797-4EE5-8C2B-2B0295FB32ED

P304

Q37384003-CB79E23A-C7CF-49B1-A288-985DBADBE2DA

P31

Q37384003-6F5C9AD9-93EA-4AAE-8E20-CAE823FF18B6

P356

Q37384003-1A343DC1-CC0E-455F-A5D2-15E5E2987F68

P407

Q37384003-35531FEB-BAF1-4DD2-9B87-8D77ED32AFCB

P433

Q37384003-070FE7E0-D4EE-46AF-A59A-917AD1900268

P478

Q37384003-60B19689-2F36-490A-A986-A36F0E228E22

P577

Q37384003-2C449B91-3F3E-4801-9249-87D31C2040C0

P698

Q37384003-3BC429E3-299D-4113-B682-6D87F9F7C354

P921

Q37384003-63024E56-1E47-46F5-B514-64400DD1A2E9

Q37384003-DFD041FA-484A-415B-B7F2-4C9A4D7450BB

P932

Q37384003-6A70CD7A-56F0-43D5-8FC4-E994A1AFB2F2

P356

P1433

Journal of Clinical Investigation

P1476

Cytotoxic T cell response agai ...... acute lymphoblastic leukemia.

@en

P2093

Duval M

http://www.w3.org/2001/XMLSchema#string

Garcia F

http://www.w3.org/2001/XMLSchema#string

Grandchamp B

http://www.w3.org/2001/XMLSchema#string

Langlade-Demoyen P

http://www.w3.org/2001/XMLSchema#string

Lemonnier F

http://www.w3.org/2001/XMLSchema#string

Peuchmaur M

http://www.w3.org/2001/XMLSchema#string

Vilmer E

http://www.w3.org/2001/XMLSchema#string

Yotnda P

http://www.w3.org/2001/XMLSchema#string

P2860

Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation

A monoclonal antibody reactive with a 15-kDa cytoplasmic granule-associated protein defines a subpopulation of CD8+ T lymphocytes.

Fusion of PDGF receptor beta to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation.

Induction of anti-tumor cytotoxic T lymphocytes in normal humans using primary cultures and synthetic peptide epitopes

Theiler's virus and Mengo virus induce cross-reactive cytotoxic T lymphocytes restricted to the same immunodominant VP2 epitope in C57BL/6 mice.

Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes.

Definition of a minimal optimal cytotoxic T-cell epitope within the hepatitis B virus nucleocapsid protein.

TEL-AML1 fusion RNA as a new target to detect minimal residual disease in pediatric B-cell precursor acute lymphoblastic leukemia.

An optimal viral peptide recognized by CD8+ T cells binds very tightly to the restricting class I major histocompatibility complex protein on intact cells but not to the purified class I protein.

High frequency of t(12;21) in childhood B-lineage acute lymphoblastic leukemia.

P304

455-462

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI3126

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

102

http://www.w3.org/2001/XMLSchema#string

P577

1998-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

9664088

http://www.w3.org/2001/XMLSchema#string

P921

P932

508905

http://www.w3.org/2001/XMLSchema#string